Home icon

Counselling Patients on the PSA Blood Test

Prostate Cancer UK’s toolkit offers an overview of updated PSA test guidance per the 2019 NICE guidelines, aiming to improve diagnostic accuracy and safety, and assists healthcare professionals in discussing the test’s pros and cons with patients to support informed decision-making.

Tens of thousands fewer men face harm in prostate cancer diagnosis

Prostate Cancer UK’s new research indicates that improved scans and safer biopsies may allow the UK to launch a prostate cancer screening program, potentially reducing deaths and harms, with the National Screening Committee considering new screening proposals.

Lived experience conversation

Meg Burgess, Senior Specialist Nurse at Prostate Cancer UK, leads a lived experience conversation with Tony, Junior, and Patrick.

Prostate mpMRI in the UK: the state of the nation

The article discusses how advancements in multiparametric MRI (mpMRI) are enhancing prostate cancer diagnosis by reducing unnecessary biopsies and targeting significant cancers, despite ongoing challenges like geographical variation and limited resources.